Enter assignee name

Forward Citations = 83

Loading Chart...

1 inventor (with patents filed for the assignee):

Alan Bruce Montgomery (10 out of 27 patents)

10 patents: Sort by Forward Citations

1. 9526698 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2016-12-27),

2. 9526697 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2016-12-27),

3. 9526696 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2016-12-27),

4. 9526695 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2016-12-27),

5. 9486462 - Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties (2016-11-08),

6. 8826904 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2014-09-09),

7. 8820323 - Methods to administer formulations of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2014-09-02),

8. 8636984 - Aerosol formulation of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2014-01-28),

9. 8636983 - Aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2014-01-28),

10. 8603439 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2013-12-10),

Cardeas Pharma Corporation is a biopharmaceutical company focused on developing innovative therapies for serious respiratory diseases. With a strong emphasis on pulmonary delivery technology, Cardeas Pharma aims to improve the lives of patients suffering from conditions such as cystic fibrosis and chronic obstructive pulmonary disease.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

10 Patents

#186 in Seattle, WA

#654 in Washington

#28,957 in US

#54,287 in the World

Seattle, WA, United States of America

Cardeas Pharma Corporation

Forward Citations = 83

1 inventor:

Alan Bruce Montgomery (10 out of 27 patents)

Please report any incorrect information to support@idiyas.com